Barbara A. Pelak - Concepedia

Concepedia

Author

Barbara A. Pelak

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

B A Pelak, B Pelak, B. A. PELAK, B. A. Pelak, B. PELAK, B. Pelak, B.A. Pelak, BARBARA A. PELAK, BARBARA ANN PELAK, Barbara A Pelak

34

Publications

1.2K

Citations

15

H-Index

35

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)MSD K.K. (Japan)United States Military Academy

BA

About

Barbara A. Pelak is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug resistance, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	754
2	Health Sciences	3	3	67
3	Biochemistry	3	3	624
4	Natural Sciences	2	2	457
5	Immunology	2	2	203

Barbara A. Pelak

×

17

Publications

1.2K

Citations

15

H-Index

	Year	Citations
Antibacterial Agents That Inhibit Lipid A Biosynthesis Hiroshi Ōnishi, Barbara A. Pelak, Lynn S. Gerckens, Science Antibacterial AgentsBiosynthesisAntimicrobial SusceptibilitySecond EnzymeBiochemistry	1996	409
Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872) Richard Hajdu, R Thompson, Jon G. Sundelof, Antimicrobial Agents and Chemotherapy Pharmaceutical ScienceLong Half-life PharmacokineticsImmunologyPharmacotherapyAntimicrobial Chemotherapy	1997	167
Difficidin and oxydifficidin: Novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis. I.Production, taxonomy and antibacterial activity. S. B. Zimmerman, Cheryl D. Schwartz, Richard L. Monaghan, The Journal of Antibiotics	1987	120
In Vivo Activity and Pharmacokinetic Evaluation of a Novel Long-Acting Carbapenem Antibiotic, MK-826 (L-749,345) Charles Gill, Jesse J. Jackson, Lynn S. Gerckens, Antimicrobial Agents and Chemotherapy	1998	68
Difficidin and oxydifficidin: Novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis. II. Isolation and physico-chemical characterization. Kenneth E. Wilson, James E. Flor, Robert E. Schwartz, The Journal of Antibiotics	1987	68
(Acyloxy)alkyl carbamate prodrugs of norfloxacin Jose Alexander, Robert A. Fromtling, Judith A. Bland, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScoreExposomicsCarbamate ProdrugsPharmaceutical Chemistry	1991	48
Cephamycins, a New Family of β-Lactam Antibiotics. IV. In Vivo Studies A. Kathrine Miller, E. Celozzi, Yu-Lin Kong, Antimicrobial Agents and Chemotherapy	1972	44
Cefoxitin, a Semisynthetic Cephamycin Antibiotic: In Vivo Evaluation A. Kathrine Miller, E. Celozzi, Yu-Lin Kong, Antimicrobial Agents and Chemotherapy	1974	40
Reduced Immunotoxicity and Preservation of Antibacterial Activity in a Releasable Side-Chain Carbapenem Antibiotic Hugh Rosen, Richard Hajdu, Lynn L. Silver, Science Antibacterial ActivityKlebsiella PneumoniaePenicillin-binding ProteinsAntimicrobial ChemotherapyAntibiotic Resistance	1999	37
Efficacy of Caspofungin against <i>Aspergillus flavus</i> , <i>Aspergillus terreus</i> , and <i>Aspergillus nidulans</i> Joel Bowman, George K. Abruzzo, Amy Flattery, Antimicrobial Agents and Chemotherapy BiosynthesisKidney Fungal BurdenAntifungal AgentEchinocandin CaspofunginMedicine	2006	36

Page 1